|
시장보고서
상품코드
1747271
세포 신호전달 시장 : 제품 유형별, 신호전달 유형별, 신호전달 경로별, 기술별, 용도별, 최종사용자별, 지역별Cell Signaling Market, By Product, By Signaling Type, By Signaling Pathway, By Technology By Application, By End User, By Region |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 세포 신호전달 시장은 2025년에 60억 8,000만 달러, 2032년에는 101억 5,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 7.6%를 보일 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024 | 2025년 시장 규모 | 60억 8,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 7.60% | 2032년 가치 예측 | 101억 5,000만 달러 |
세계 세포 신호전달 시장은 생명공학 및 의학 연구 분야에서 중요한 역할을 하는 빠르게 발전하고 있는 분야입니다. 신호전달이라고도 알려진 세포 신호전달은 세포의 성장, 분화, 대사, 세포사멸 등 다양한 세포 활동을 지배하는 복잡한 커뮤니케이션 과정을 말합니다. 이 복잡한 신호전달 경로의 네트워크는 세포 표면에서 핵으로의 신호전달을 포함하며, 특정 세포 반응을 유발합니다. 세포 신호전달 시장은 이러한 신호전달 경로를 연구하고 조작하는 데 사용되는 시약, 분석 키트, 기기, 소프트웨어 등 다양한 제품과 기술을 포괄합니다. 만성질환 증가와 맞춤의료에 대한 수요 증가로 인해 세포 신호전달 시장은 향후 몇 년 동안 크게 성장할 것으로 예측됩니다.
시장 역학:
세계 세포 신호전달 시장은 세포 신호전달 경로의 이상과 관련된 암, 당뇨병, 심혈관 질환과 같은 만성 질환의 발병률 증가 등 여러 요인에 의해 주도되고 있습니다. 표적 치료 및 맞춤 의료에 대한 수요 증가는 이 시장의 성장을 더욱 촉진하고 있습니다. 세포 신호전달 연구는 새로운 신약 타겟을 발굴하고 표적 치료제를 개발하는 데 중요한 역할을 하고 있기 때문입니다. 또한, 세포생물학 분야의 연구개발 활동에 대한 관심이 증가하고 정부 및 민간단체의 자금 지원이 증가함에 따라 시장 성장을 가속할 것으로 예측됩니다. 그러나 세포 신호 제품 및 기술의 높은 비용과 숙련된 전문가의 부족은 시장 성장을 어느 정도 저해할 수 있습니다. 또한, 신약 개발 과정에 대한 엄격한 규제 요건은 시장 참여자들에게 도전이 될 수 있습니다. 이러한 시장 성장 억제요인에도 불구하고, 세포 신호전달 시장은 특히 의료비 증가와 선진 의료기술에 대한 인식 증가가 시장 확대의 원동력이 될 것으로 예상되는 신흥국에서 큰 성장 기회를 제공합니다.
본 조사의 주요 특징
- 세계의 세포 신호전달 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 세포 신호 전달 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 세포 신호전달 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 세포 신호전달 시장, 제품별, 2020년-2032년
- 소모품
- 기기
제5장 세계의 세포 신호전달 시장, 신호전달 유형별, 2020년-2032년
- Intracrine ligands
- Autocrine ligands
- Juxtacrine ligand
- Paracrine ligands
- Endocrine ligands
제6장 세계의 세포 신호전달 시장, 신호전달 경로별, 2020년-2032년
- MAPK/ERK 경로
- PI3K/Akt 경로
- Wnt 경로
- Notch 신호전달 경로
- NF-κB 경로
- JAK/STAT 경로
- TGF-B 경로
- 칼슘 신호전달 경로
제7장 세계의 세포 신호전달 시장, 기술별, 2020년-2032년
- 현미경 검사
- 유세포 분석기
- 웨스턴 블로팅
- ELISA
- 질량분석
- 면역조직화학
- 기타
제8장 세계의 세포 신호전달 시장, 용도별, 2020년-2032년
- 암 연구
- 면역학
- 신경과학
- 심장혈관 연구
- 줄기세포 연구
- 기타(대사장애 등)
제9장 세계의 세포 신호전달 시장, 최종사용자별, 2020년-2032년
- 제약 및 바이오테크놀러지 기업
- 학술연구기관
- 병원 및 임상 실험실
- 정부기관
- 수탁 연구기관
제10장 세계의 세포 신호전달 시장, 지역별, 2020년-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- GE Healthcare
- Roche Diagnostics
- Sigma-Aldrich(part of Merck Group)
- Abcam
- PerkinElmer
- Becton, Dickinson and Company
- Agilent Technologies
- Promega Corporation
- Cell Signaling Technology
- QIAGEN
- MilliporeSigma
- Takara Bio
제12장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사에 대해
Global Cell Signaling Market is estimated to be valued at USD 6.08 Bn in 2025 and is expected to reach USD 10.15 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 6.08 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.60% | 2032 Value Projection: | USD 10.15 Bn |
The global cell signaling market is a rapidly evolving sector that plays a crucial role in the field of biotechnology and medical research. Cell signaling, also known as signal transduction, refers to the complex communication process that governs various cellular activities, such as cell growth, differentiation, metabolism, and apoptosis. This intricate network of signaling pathways involves the transmission of signals from the cell surface to the nucleus, triggering specific cellular responses. The cell signaling market encompasses a wide range of products and technologies, including reagents, assay kits, instruments, and software, which are used to study and manipulate these signaling pathways. With the increasing prevalence of chronic diseases and the growing demand for personalized medicine, the cell signaling market is poised for significant growth in the coming years.
Market Dynamics:
The global cell signaling market is driven by several factors, including the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which are associated with aberrant cell signaling pathways. The increasing demand for targeted therapies and personalized medicine has further fueled the growth of this market, as cell signaling research plays a vital role in identifying novel drug targets and developing targeted therapeutics. Moreover, the growing focus on research and development activities in the field of cell biology, coupled with the increasing funding from government and private organizations, is expected to propel the market growth. However, the high cost of cell signaling products and technologies, along with the lack of skilled professionals, may hinder the market growth to some extent. Additionally, the stringent regulatory requirements for drug discovery and development processes may pose challenges to market players. Despite these restraints, the cell signaling market presents significant opportunities for growth, particularly in emerging economies, where the increasing healthcare expenditure and growing awareness about advanced medical technologies are expected to drive the market expansion.
Key Features of the Study:
- This report provides in-depth analysis of the global cell signaling market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cell signaling market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Roche Diagnostics, Sigma-Aldrich (part of Merck Group), Abcam, PerkinElmer, Becton, Dickinson and Company, Agilent Technologies, Promega Corporation, Cell Signaling Technology, QIAGEN, MilliporeSigma, and Takara Bio
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cell signaling market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell signaling market
Market Segmentation
- Product Insights (Revenue, USD Bn, 2020 - 2032)
- Consumables
- Instruments
- Signaling Type Insights (Revenue, USD Bn, 2020 - 2032)
- Intracrine ligands
- Autocrine ligands
- Juxtacrine ligand
- Paracrine ligands
- Endocrine ligands
- Signaling Pathway Insights (Revenue, USD Bn, 2020 - 2032)
- MAPK/ERK Pathway
- PI3K/Akt Pathway
- Wnt Pathway
- Notch Signaling Pathway
- NF-kB Pathway
- JAK/STAT Pathway
- TGF-B Pathway
- Calcium Signaling Pathway
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Microscopy
- Flow Cytometry
- Western Blotting
- ELISA
- Mass Spectrometry
- Immunohistochemistry
- Others
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cancer Research
- Immunology
- Neuroscience
- Cardiovascular Research
- Stem Cell Research,
- Others (Metabolic disorders, etc.)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutions
- Hospitals and Clinical Laboratories
- Government Agencies
- Contract Research Organizations
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- GE Healthcare
- Roche Diagnostics
- Sigma-Aldrich (part of Merck Group)
- Abcam
- PerkinElmer
- Becton, Dickinson and Company
- Agilent Technologies
- Promega Corporation
- Cell Signaling Technology
- QIAGEN
- MilliporeSigma
- Takara Bio
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cell Signaling Market, By Product
- Global Cell Signaling Market, By Signaling Type
- Global Cell Signaling Market, By Signaling Pathway
- Global Cell Signaling Market, By Technology
- Global Cell Signaling Market, By Application
- Global Cell Signaling Market, By End User
- Global Cell Signaling Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cell Signaling Market, By Product, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Cell Signaling Market, By Signaling Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Intracrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autocrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Juxtacrine ligand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Paracrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Endocrine ligands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Cell Signaling Market, By Signaling Pathway, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- MAPK/ERK Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- PI3K/Akt Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Wnt Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Notch Signaling Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- NF-kB Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- JAK/STAT Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- TGF-B Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Calcium Signaling Pathway
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Cell Signaling Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Western Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunohistochemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Cell Signaling Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neuroscience
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stem Cell Research,
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Metabolic disorders, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Cell Signaling Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals and Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Cell Signaling Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Signaling Pathway, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma-Aldrich (part of Merck Group)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Signaling Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MilliporeSigma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록